Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS). CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical Trials Directive or under the new Clinical Trials Regulation (CTR), which entered into application on 31 January 2022.
Read the news announcement on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (19 avril 2023). Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o68v





